BT Slingsby

Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA.

Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN.

Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.

SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA.

Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT.

Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey.

Part of Broadcom Inc., The ASK Group, Inc. is a turnkey vendor that provides computer systems. The company is based in Mountain View, CA. The ASK Group was acquired by CA Technologies, Inc., part of Broadcom Inc. from November 06, 2018 on June 24, 1994 for $308.70 million. The company was founded by Sandra L. Kurtzig.

SDI Technologies, Inc. manufactures audio equipment and consumer electronics. Its products include alarm clocks, clock radios, satellite radios, speaker systems and iPod accessories. The company was founded in 1956 and is headquartered in Rahway, NJ.

Resonant Medical Inc. develops, manufactures and distributes 3D ultrasound image-guided adaptive radiotherapy products. The company was founded by Fred Francis, Tony Falco and Luc Sirois and is headquartered in Montréal, CA.

U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY.

IQS, Inc. provides integrated quality performance management software solutions. The firm’s quality management services include quality management software implementation, software validation services and IQS software training. The company was founded by John M. Cachat in 1988 and is headquartered in North Olmsted, OH.

National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL.

Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY.

Right Care Solutions, Inc. develops a discharge decision support platform. It offers risk assessment by flagging patients at risk for readmissions when admitted to the hospital. The solution also provides recommendations regarding post-acute care and community-based services for patients. The company was founded by Eric M. Heil and Kathyrn H. Bowles in 2011 and is headquartered in Horsham, PA.

Abyrx, Inc. develops, manufactures, and markets medical therapeutic devices. It offers montage, hemasorb, heamsorb plus, hemasorb apply, and absorbable hemostatic bone putty. The company was founded in 2013 and is headquartered in Irvington, NY.

Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA.

Nexcida Therapeutics, Inc. operates in the field of infectious disease therapeutics. The company was founded by Yigong Ge and is headquartered in Menlo Park, CA.

Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE.

Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN.

Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland.

Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom.

Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom.

Healyx Labs, Inc. is an innovative medical device company, which engages in the implementation of wound healing. Its solutions include negative pressure wound therapy. The company was founded by Cam Hutton, Cassie Ludwig, Matias Rivera, and Tiffany Kung in 2015 ad is headquartered in Mountain View, CA.

Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead.

Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021.